Definitive Healthcare Corp (DH) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Definitive Healthcare Corp stock (DH) is currently trading at $1.11. Definitive Healthcare Corp PS ratio (Price-to-Sales) is 0.49. Analyst consensus price target for DH is $2.77. WallStSmart rates DH as Sell.
- DH PE ratio analysis and historical PE chart
- DH PS ratio (Price-to-Sales) history and trend
- DH intrinsic value — DCF, Graham Number, EPV models
- DH stock price prediction 2025 2026 2027 2028 2029 2030
- DH fair value vs current price
- DH insider transactions and insider buying
- Is DH undervalued or overvalued?
- Definitive Healthcare Corp financial analysis — revenue, earnings, cash flow
- DH Piotroski F-Score and Altman Z-Score
- DH analyst price target and Smart Rating
Definitive Healthcare Corp
📊 No data available
Try selecting a different time range
Smart Analysis
Definitive Healthcare Corp (DH) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, institutional own.. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Definitive Healthcare Corp (DH) Key Strengths (3)
Paying less than $1 for every $1 of annual revenue
Trading below book value, meaning the market prices it less than net assets
88.70% of shares held by major funds and institutions
Supporting Valuation Data
Definitive Healthcare Corp (DH) Areas to Watch (5)
Company is destroying shareholder value
Losing money on operations
Revenue declining -1.20%, a shrinking business
Company is losing money with a negative profit margin
Micro-cap company with very limited liquidity and high volatility
Definitive Healthcare Corp (DH) Detailed Analysis Report
Overall Assessment
This company scores 35/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 3 register as strengths (avg 10.0/10) while 5 fall into concern territory (avg 0.6/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book, Institutional Own.. Valuation metrics including Price/Sales (0.49), Price/Book (0.41) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Growth concerns include Revenue Growth at -1.20%, which may limit upside. Profitability pressure is visible in Return on Equity at -40.40%, Operating Margin at -10.90%, Profit Margin at -57.50%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -40.40% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -1.20% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
DH Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
DH's Price-to-Sales ratio of 0.49x trades at a deep discount to its historical average of 6.05x (2th percentile). The current valuation is 99% below its historical high of 38.63x set in Sep 2021, and 6% above its historical low of 0.46x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~1.2x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Definitive Healthcare Corp (DH) · HEALTHCARE › HEALTH INFORMATION SERVICES
The Big Picture
Definitive Healthcare Corp is in a turnaround phase, with management focused on restoring profitability. Revenue reached 242M with 120% decline year-over-year. The company is currently unprofitable, posting a -57.5% profit margin.
Key Findings
Revenue contracted 120% YoY. Worth determining whether this is cyclical or structural.
The company is unprofitable with a -57.5% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Volatility is elevated with a beta of 1.66, so expect amplified moves relative to the broader market.
Sector dynamics: monitor HEALTH INFORMATION SERVICES industry trends, competitive moves, and regulatory changes that could impact Definitive Healthcare Corp.
Bottom Line
Definitive Healthcare Corp is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(10 last 3 months)
| Insider | Type | Shares |
|---|---|---|
COOP, KEVIN Director, Chief Executive Officer | Sell | -175,524 |
| Insider | Type | Shares |
|---|---|---|
HELLER, CASEY Chief Financial Officer | Buy | +195,313 |
| Insider | Type | Shares |
|---|---|---|
COOP, KEVIN Director, Chief Executive Officer | Sell | -28,236 |
Data sourced from SEC Form 4 filings
Last updated: 8:22:17 AM
About Definitive Healthcare Corp(DH)
NASDAQ
HEALTHCARE
HEALTH INFORMATION SERVICES
USA
Definitive Healthcare Corp (DH) is a leading provider of data and analytics solutions specifically designed for the healthcare industry, catering to a diverse clientele that includes pharmaceutical companies, payers, and healthcare providers. Utilizing vast datasets and real-time analytics, DH enhances operational efficiency and informs strategic insights that drive better patient outcomes. The company is well-positioned to capitalize on the growing demand for healthcare analytics, paving the way for optimized performance amid an increasingly complex industry landscape. By partnering with key stakeholders, Definitive Healthcare focuses on delivering innovative solutions that offer a competitive edge and foster operational excellence across the sector.